In US military, white kids, officers' kids more likely to use diabetes technology

April 3, 2017, The Endocrine Society

Even with equal access to healthcare in the United States military, significant disparities in caring for children with type 1 diabetes still exist, new research reports. The results of the study will be presented Monday, April 3, at ENDO 2017, the annual meeting of the Endocrine Society, in Orlando.

"Patients now have greater access to technology to help them manage type 1 diabetes, and some studies have reported significantly better glycemic control with the use of technology," lead study author Rachael Paz, M.D., a pediatric endocrinology fellow at Walter Reed National Military Medical Center in Bethesda, Md., said.

"Even in the U.S. military healthcare system, with equal access to and coverage of most healthcare costs, inequalities exist in the control of type 1 diabetes and in the use of and continuous glucose monitors (CGMs)," Paz noted. "These disparities in the utilization of currently available diabetes technology may be contributing to the differences in glycemic control we find between certain patient populations."

Paz and her colleagues investigated whether, within the military health system, differences exist in the use of diabetes technology and if differs between patients who use diabetes technologies and those who don't.

They retrospectively reviewed the charts of patients between 2 and 19 years of age whose parent were members of the U.S. military. These dependents had type 1 diabetes and were seen at the Walter Reed pediatric endocrinology clinics between January 2006 and August 2016.

The authors excluded patients who had diabetes for less than one year, those who took less than 0.5 units of insulin per kg per day, and those with underlying conditions that called for a higher hemoglobin A1c (HbA1c) goal. Due to small numbers, they also excluded those on NPH (neutral protamine Hagedorn) insulin from their analysis.

Among the 405 dependent patients who met the inclusion criteria, the median age was 16 years, the median duration was 6 years, and the median HbA1C was 8.7 percent. Overall, 46.2 percent of the children were female, 68.1 percent were white, and 53.8 percent were dependents of officers, not enlisted personnel.

For treatment, 49.1 percent used an insulin pump, 20.2 percent used a CGM, and 16.5 percent had both a pump and a CGM. Insulin pumps were used more often by white children and officers' children. CGMs were also used more often by white children and officers' .

Patients using an insulin pump were more likely to use a CGM as well: 34 percent of patients on an pump had a CGM compared to 7 percent of those on multiple daily injections (MDI).

Patients using a pump had lower median HbA1C tests showing the average blood sugar level over the previous three months than those on MDI (8.4 percent versus 9.1 percent); and those using a CGM also had lower median HbA1C than those who did not (8.1 percent vs 8.9 percent).

Diabetes-related hospitalizations were similar whether a pump or MDI was used (30.2 percent vs 30.6 percent). Only 19.5 percent of patients with a CGM had a history of hospitalization compared with 33.1 percent of those without the device.

"We need to identify the root causes of these differences and devise processes that eliminate them so all our can have the greatest opportunity to optimize their health," Paz said.

Explore further: Can continuous glucose monitoring improve diabetes control in patients with type 1 diabetes who inject insulin

Related Stories

Can continuous glucose monitoring improve diabetes control in patients with type 1 diabetes who inject insulin

January 24, 2017
Two studies in the January 24/31 issue of JAMA find that use of a sensor implanted under the skin that continuously monitors glucose levels resulted in improved levels in patients with type 1 diabetes who inject insulin multiple ...

ADA recommends metformin as the preferred drug treatment for type 2 diabetes

March 13, 2017
The American Diabetes Association (ADA) recommends metformin as the first-line treatment for type 2 diabetes. Metformin monotherapy should be initiated at the time of diagnosis for most patients unless there are contraindications. ...

Artificial pancreas improves blood sugar control in young kids

April 3, 2017
An artificial pancreas, which delivers insulin in an automated way to individuals with type 1 diabetes, appears to be safe and effective for use in children ages 5 to 8 years, a new study finds. Results will be presented ...

Durable response with insulin pump therapy in T2DM

February 12, 2016
(HealthDay)—Insulin pump therapy is more effective than multiple daily injections (MDI) for glycemic control in patients with type 2 diabetes, according to a study published online Feb. 8 in Diabetes, Obesity and Metabolism.

Disparities in insulin pump use by New Zealanders with type 1 diabetes

September 23, 2016
There are significant demographic and regional disparities in the use of insulin pumps in New Zealand, according to new University of Otago research.

Basal insulin peglispro beats glargine for glycemic control

November 30, 2015
(HealthDay)—For patients with type 2 diabetes, basal insulin peglispro (BIL) provides better glycemic control than insulin glargine, with increased triglycerides, aminotransferases, and liver fat content, according to a ...

Recommended for you

Study reveals the current rates of diagnosed type 1 and type 2 diabetes in American adults

September 18, 2018
A new study from the University of Iowa finds that type 2 diabetes remains overwhelmingly the most common type of diabetes diagnosed in American adults who have the disease.

Research reveals link between immunity, diabetes

September 14, 2018
When it comes to diet-induced obesity, your immune system is not always your friend.

BPA exposure in U.S.-approved levels may alter insulin response in non-diabetic adults

September 14, 2018
In a first study of its kind study, researchers have found that a common chemical consumers are exposed to several times a day may be altering insulin release. Results of the study, led by scientists at the University of ...

High blood sugar during pregnancy ups risk of mother's type 2 diabetes, child's obesity

September 11, 2018
Mothers with elevated blood glucose during pregnancy—even if not high enough to meet the traditional definition of gestational diabetes—were significantly more likely to have developed type 2 diabetes a decade after pregnancy ...

Want to avoid type 2 diabetes? Eat more whole grains

September 11, 2018
(HealthDay)—It may seem counterintuitive, but eating bread, pasta and cereal may actually help prevent type 2 diabetes, as long as those foods are made from whole grains, new research suggests.

Exercise could delay progression of type 1 diabetes when first diagnosed

September 5, 2018
The findings of a study led by the University of Birmingham suggests that exercise during the first few months of diagnosis of type 1 diabetes could delay the progression of the condition.

0 comments

Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.